Health ❯ Regulatory Affairs

FDA

Drug Approval Process Drug Approval Drug Safety Drug Recalls Clinical Trials Drug Regulations Vaccine Approval Process Food Recalls Vaccine Authorization Product Safety Drug Shortages Recalls Product Monitoring Drug Warnings Medical Device Safety Medical Device Approval Product Recalls Drug Labeling Recall Classification Ingredient Approval Biologics License Application Cosmetics Regulation Enforcement Actions Drug Classification E-Cigarettes Cosmetic Approvals Generic Drug Applications Drug Regulation Drug Approvals Advisory Committees

FDA Panel Rejects Deramiocel Cardiac Claim After Lancet Publishes HOPE‑3 Results

A 9–3 advisory vote and critical FDA reviews increase doubt about final approval ahead of the August 22 PDUFA date.

FDA Staff Flags Major Flaws in Capricor’s Deramiocel Data

Fulcrum Halts Pociredir Development After FDA Flags PRC2 Cancer Risk

Theriva’s VCN-01 Extends Survival in Phase 2b Pancreatic Cancer Trial, Paving Way to Phase 3

Peptide Craze Grows as HHS Chief Backs Wider Access

FDA Upgrades Children’s Ibuprofen Recall to Class II Over Reports of Foreign Material

Novo Nordisk Strikes Hims & Hers Deal for Ozempic and Wegovy, Drops Patent Suit

FDA Recalls Specific FreeStyle Libre 3 Sensors Over Faulty Low-Glucose Readings

Sarepta Reports 3-Year EMBARK Data Showing Elevidys Slows Duchenne Progression

Bristol Myers Delays ADEPT-2 Alzheimer’s Psychosis Readout to 2026 After Site Irregularities

Wawa Recalls Select 16-Ounce Milk and Lemonade Sold in 4 States

Sarepta Shares Plummet on FDA Review of Elevidys Following Third Patient Death

FDA Warns of Rare Severe Itching After Stopping Common Allergy Medications